The European Union has adopted new rules requiring member states to include non-price criteria such as sustainability, resilience, and project execution in renewable energy auctions.

EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial methotrexate therapy fails.

BARCELONA, Spain-- (BUSINESS WIRE)-- Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting showing that an ...

At the European Congress of Rheumatology (EULAR) 2025, Scipher Medicine, the company behind the groundbreaking PrismRA ® test, unveiled a new, AI-driven approach to help doctors better evaluate ...

Gout flares are associated with cardiovascular events. Treating gout to target serum urate levels prevents flares, but whether such treatment can also prevent cardiovascular events is unknown.

Biogen, UCB Present Positive Phase 3 Results for Lupus Drug Candidate at EULAR 2025 Published on June 15, 2025 at 5:38 am by Maham Fatima in News ...

Three of four patients with refractory non-renal SLE achieved complete remission, she told attendees at the European Alliance of Associations for Rheumatology's (EULAR) annual meeting. She added ...

Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting showing that an artificial intelligence (AI)-based ...

More information: Moltó A, et al. Inequity in access to care for rheumatic and musculoskeletal diseases is a reality in Europe: first data from the EULAR Rheumafacts project.

BARCELONA, Spain-- (BUSINESS WIRE)-- Hospital for Special Surgery (HSS) presented new findings at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting that could help pave the ...

BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis ...

EULAR – The European Alliance of Associations for Rheumatology – the leading organisation for rheumatic and musculoskeletal diseases (RMDs) in Europe is delighted to welcome Professor Xenofon ...